Prelude Therapeutics
PRLD
#9259
Rank
S$71.73 M
Marketcap
$1.30
Share price
0.57%
Change (1 day)
-69.83%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2023 (TTM): -$2.92

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.92. In 2022 the company made an earnings per share (EPS) of -$3.29 a decrease over its 2021 EPS that were of -$3.26.

EPS history for Prelude Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.92-11.15%
2022-$3.290.83%
2021-$3.26-61.3%
2020-$8.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.94 0.46%๐Ÿ‡บ๐Ÿ‡ธ USA